Patent application number | Description | Published |
20080230109 | Solar Cell Module and Method For Its Production - A solar cell module and a method for the production thereof, are used in particular in the field of concentrating solar technology. The solar cell module has a large number of two-dimensionally disposed solar cells. These solar cells are applied on a substrate which is coated with a metal layer on the surface orientated towards the solar cells. The metal layer is thereby structured in such a manner that it is subdivided into individual two-dimensional portions which are assigned respectively to one solar cell. The metal layer in each of the portions has two regions which are electrically insulated from each other, the first region extending under the assigned solar cell and contacting the latter in an electrically conductive manner. The second region is likewise connected to the other electrical contact of the solar cell. In order to produce a parallel and series circuit of the individual solar cells, the individual portions of the metal layer are now connected to each other in a suitable manner by means of connecting portions which, for their part, are part of the metal layer. | 09-25-2008 |
20090126794 | Photovoltaic Concentrator Module With Multifunction Frame - The invention relates to a photovoltaic concentrator module with multifunction frame and also to a method for production thereof. The concentrator module has a lens—( | 05-21-2009 |
20090272427 | PHOTOVOLTAIC MODULE AND THE USE THEREOF - The present invention relates to a photovoltaic module, comprising at least two component cell groups (SCA) which are connected to each other and disposed on an electrically insulating basic body, which groups comprise respectively one solar cell which is applied on a thermally and electrically conductive carrier and a bypass diode which is applied at a spacing thereto, and which are contacted with each other via an electrical conductor, the bypass diode having a polarity which is inverse to the solar cell and the solar cell and the bypass diode being applied on the conductive carrier via a conductive connecting layer. | 11-05-2009 |
20110048501 | SOLAR CELL MODULE - The invention relates to a solar cell module comprising at least two assemblies (SCA) which are connected to each other and have solar cells and also a module base plate comprising an electrically conductive carrier structure and a rear-side plate which is electrically insulated at least on the side orientated towards the carrier structure. The assembly comprising the solar cell is thereby particularly small with respect to dimensioning, which leads to low material consumption of heat sink material, e.g. copper and aluminium, and hence enables particularly economical production. | 03-03-2011 |
20110127546 | REFLECTIVE SECONDARY LENS SYSTEM AND SEMICONDUCTOR ASSEMBLY AND ALSO METHOD FOR THE PRODUCTION THEREOF - The present invention relates to a reflective and/or refractive secondary lens system for focusing sunlight onto semiconductor elements, the secondary lens system being characterised according to the invention by a projection which is disposed around the basic body forming the secondary lens system. Furthermore, the present invention relates to a semiconductor assembly which includes the secondary lens system according to the invention, and also to a method for the production of this semiconductor assembly. In particular, this semiconductor assembly represents a concentrating solar cell module. | 06-02-2011 |
20110265852 | OPEN ENCAPSULATED CONCENTRATOR SYSTEM FOR SOLAR RADIATION - The invention relates to an open concentrator system for solar radiation comprising a hollow mirror and a photovoltaic module comprising a plurality of solar cells disposed in the focus of said hollow mirror, the photovoltaic module being encapsulated by a housing. The housing is thereby configured such that it has a transparent cover at least in the region of the incident radiation reflected by the hollow mirror and such that this transparent cover is at a spacing from photovoltaic module, i.e. is situated in the cone of the incident radiation. | 11-03-2011 |
20120187439 | SOLAR CELL ASSEMBLY AND ALSO SOLAR CELL ARRANGEMENT - The invention relates to a light-absorbing or light-emitting solar cell assembly and also a solar cell arrangement which is constructed from 2 to 10,000 of the solar cell assemblies according to the invention. | 07-26-2012 |
20140190554 | MONOLITHIC MULTIPLE SOLAR CELLS - A monolithic multiple solar cell includes at least three partial cells, with a semiconductor mirror placed between two partial cells. The aim of the invention is to improve the radiation stability of said solar cell. For this purpose, the semiconductor mirror has a high degree of reflection in at least one part of a spectral absorption area of the partial cell which is arranged above the semiconductor mirror and a high degree of transmission within the spectral absorption range of the partial cell arranged below the semiconductor mirror. | 07-10-2014 |
20140190559 | MONOLITHIC MULTIPLE SOLAR CELLS - A monolithic multiple solar cell includes at least three partial cells, with a semiconductor mirror placed between two partial cells. The aim of the invention is to improve the radiation stability of said solar cell. For this purpose, the semiconductor mirror has a high degree of reflection in at least one part of a spectral absorption area of the partial cell which is arranged above the semiconductor mirror and a high degree of transmission within the spectral absorption range of the partial cell arranged below the semiconductor mirror. | 07-10-2014 |
20150053257 | MULTI-JUNCTION SOLAR CELL AND USE THEREOF - The present invention relates to a multi junction solar cell having at least four p-n junctions. The individual subcells thereby have band gaps of 1.9 eV, 1.4 eV, 1.0 eV and 0.7 eV. The multi junction solar cells according to the invention are used in space and also in terrestrial concentrator systems. | 02-26-2015 |
20150380591 | ADJUSTMENT-TOLERANT PHOTOVOLTAIC CELL - An adjustment-tolerant photovoltaic cell in which the front face has at least three sub-segments which can be directly struck by electromagnetic radiation is provided. At least two sub-segments are in the form of a first segment type, and at least one sub-segment is in the form of a second segment type. The sub-segments can be arranged such that at least two separate segment regions, which can be directly struck by the electromagnetic radiation, are formed for each of the first and the second segment types. At least two sub-segments of the first segment type can be connected to each other in parallel and/or are connected to each other via a transition region which ensures the lateral flow of current. Furthermore, the sub-segments of the first segment type can be connected in series to the at least one sub-segment of the second segment type. | 12-31-2015 |
Patent application number | Description | Published |
20150027519 | MANUFACTURE OF MULTIJUNCTION SOLAR CELL DEVICES - The present disclosure relates to a method for manufacturing a multi-junction solar cell device comprising the steps of: providing a first substrate, providing a second substrate having a lower surface and an upper surface, forming at least one first solar cell layer on the first substrate to obtain a first wafer structure, forming at least one second solar cell layer on the upper surface of the second substrate to obtain a second wafer structure, and bonding the first wafer structure to the second wafer structure, wherein the at least one first solar cell layer is bonded to the lower surface of the second substrate and removing the first substrate. | 01-29-2015 |
20150083202 | MANUFACTURE OF MULTIJUNCTION SOLAR CELL DEVICES - The present disclosure relates to a method for manufacturing a multi-junction solar cell device comprising the steps of: providing a first engineered substrate; providing a second substrate; forming at least one first solar cell layer on the first engineered substrate to obtain a first wafer structure; forming at least one second solar cell layer on the second substrate to obtain a second wafer structure; bonding the first wafer structure to the second wafer structure; detaching the first engineered substrate; removing the second substrate; and bonding a third substrate to the at least one first solar cell layer. | 03-26-2015 |
20150372179 | MULTI-JUNCTION SOLAR CELL, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF - A multi-junction solar cell having at least three p-n junctions is proposed, which comprises a rear-side subcell comprising GaSb, which has at least one p-n junction, and a front-side subcell which has at least two p-n junctions and which is characterised in that the rear-side subcell has a ≧2%, in particular >4%, larger lattice constant than the front-side subcell and the two subcells are connected to each other via an optically transparent and electrically conductive wafer-bond connection. The multi-junction solar cell achieves a high absorption up to the band gap energy of the lowermost GaSb-comprising subcell and a photoelectric voltage which is increased relative to multi-junction solar cells from the state of the art. Furthermore, methods for the production of the multi-junction solar cell according to the invention are presented and uses of the multi-junction solar cell according to the invention are indicated. | 12-24-2015 |
Patent application number | Description | Published |
20080254059 | Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby - Adenoviral serotypes differ in their natural tropism. The various serotypes of adenovirus have been found to differ in at least their capsid proteins (e.g., penton-base and hexon proteins), proteins responsible for cell binding (e.g., fiber proteins), and proteins involved in adenovirus replication. This difference in tropism and capsid proteins among serotypes has led to many research efforts aimed at redirecting the adenovirus tropism by modification of the capsid proteins. The present invention bypasses such requirement for capsid protein modification as it presents a recombinant, replication-defective adenovirus of serotype 26, a rare adenoviral serotype, and methods for generating the alternative, recombinant adenovirus. Additionally, means of employing the recombinant adenovirus for delivery and expression of heterologous genes are provided. | 10-16-2008 |
20090233992 | HEPATITIS C VIRUS VACCINE - The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region. The nucleic acid is particularly useful as a component of an adenovector or DNA plasmid vaccine providing a broad range of antigens for generating an HCV specific cell mediated immune (CMI) response against HCV. | 09-17-2009 |
20100129901 | HEPATITIS C VIRUS VACCINE - The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region. The nucleic acid is particularly useful as a component of an adenovector or DNA plasmid vaccine providing a broad range of antigens for generating an HCV specific cell mediated immune (CMI) response against HCV. | 05-27-2010 |
20100183651 | Broadly Representative Antigen Sequences and Method for Selection - A novel method for generating vaccine sequences is disclosed herein that preserves contiguous epitope length stretches of amino acids or nucleotides from an input pool of sequences. The method generates continuous, stepwise epitope consensus that together provides for a single globally optimized sequence. The end sequences are designed to maximize overlap between any potential epitope length sequence extract from a natural antigen sequence. The disclosed method, thus, allows one to maximize the number of potential natural epitopes that are mimicked in a resultant vaccine sequence. Various representative HIV vaccine sequences have been generated and are disclosed herein. | 07-22-2010 |
20100272714 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 10-28-2010 |
20110159013 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLS, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 06-30-2011 |
20120171224 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLS, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 07-05-2012 |
20130216575 | RECOMBINANT SUBUNIT DENGUE VIRUS VACCINE - The present invention provides dengue virus vaccines and immunogenic compositions for administration to human subjects. The vaccine compositions of the present invention comprise recombinantly produced monomeric and/or dimeric forms of truncated dengue virus envelope glycoprotein that, when formulated together with an adjuvant and a pharmaceutically acceptable carrier, induce balanced tetravalent immune responses. In preferred embodiments of the compositions described herein, the DEN4 protein component is a dimeric form of DEN4. The compositions are designed to be acceptable for use in the general population, including immunosuppressed, immunocompromised, and immunosenescent individuals. Also provided herein are methods of inducing a protective immune response in a human patient population by administering the compositions described herein to the patients. | 08-22-2013 |
20160074502 | RECOMBINANT SUBUNIT DENGUE VIRUS VACCINE - The present invention provides dengue virus vaccines and immunogenic compositions for administration to human subjects. The vaccine compositions of the present invention comprise recombinantly produced monomeric and/or dimeric forms of truncated dengue virus envelope glycoprotein that, when formulated together with an adjuvant and a pharmaceutically acceptable carrier, induce balanced tetravalent immune responses. In preferred embodiments of the compositions described herein, the DEN4 protein component is a dimeric form of DEN4. The compositions are designed to be acceptable for use in the general population, including immunosuppressed, immunocompromised, and immunosenescent individuals. Also provided herein are methods of inducing a protective immune response in a human patient population by administering the compositions described herein to the patients. | 03-17-2016 |